Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
281. |
ECCT/19/01/02 | Opt4Kids Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids) |
Principal Investigator(s) 1. Lisa Dillabaugh Abuogi 2. Patrick Oyaro Owiti Site(s) in Kenya 1. Kisumu County Hospital (Kisumu county) 2. Ahero County Hospital (Kisumu county) 3. Nyakach County Hospital (Kisumu county) 4. Lumumba sub-County Hospital (Kisumu county) 5. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) |
View |
282. |
ECCT/19/01/01 | A Randomized, Open, Parallel-group, Single Dose, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel in combination with Ferroquine (FQ) and FQ alone, in African Patients with Unc A Randomized, Open label, Parallel-group, Single Dose Regimen, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel (OZ439) given in combination with Ferroquine (FQ) and FQ alone, in African Patients with Uncomplicated Plasmodium falciparum Malaria |
Principal Investigator(s) 1. Bernhards Ogutu Ragama Site(s) in Kenya 1. Ahero County hospital (Kisumu county) 2. Siaya County Hospital (Siaya county) |
View |
283. |
ECCT/18/12/02 | Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod |
Principal Investigator(s) 1. CHRISTOPHER L. MELBY MELBY Site(s) in Kenya KENYA MEDICAL RESEARCH INSTITUTE |
View |
284. |
ECCT/18/12/01 | study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants. A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya. |
Principal Investigator(s) 1. Mainga Hamaluba Site(s) in Kenya KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya. |
View |
285. |
ECCT/18/11/02 | EPI 003 A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa. |
Principal Investigator(s) 1. BERNHARDS OGUTU Site(s) in Kenya 1. • Ahero Clinical Trials Unit (Kisumu county) 2. KEMRI Walter Reed Army Institute of Research (Kisumu county) 3. KEMRI CDC SIAYA (Siaya county) |
View |